ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "MPS 1: Where are we now?"
Episode Synopsis
Dr Sandra Kingma from the Centre for Rare Diseases in Antwerp joins the podcast to discuss all things Mucopolysaccharidosis type I. Her recent paper asks 'where are we now?' and I asked her about where we are going next?
MPS I: Early diagnosis, bone disease and treatment, where are we now?
Sandra D. K. Kingma, An I. Jonckheere,
First published: 03 September 2021 https://doi.org/10.1002/jimd.12431
MPS I: Early diagnosis, bone disease and treatment, where are we now?
Sandra D. K. Kingma, An I. Jonckheere,
First published: 03 September 2021 https://doi.org/10.1002/jimd.12431
More episodes of the podcast JIMD Podcasts
Shortcast: Liver Directed Rx don’t change biochemistry nor Leukodystrophy in Biallelic HMBS Variants
30/12/2025
Sixty Years of Metabolic Medicine: A Conversation with Jean-Marie Saudubray and Manuel Schiff
23/12/2025
Shortcast: Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders
25/11/2025
IMD Research Round-Up: Mitochondrial disease
11/11/2025
In God we trust